Article
TP53 mutations in human cancers: origins, consequences, and clinical use.
Cold Spring Harbor perspectives in biology - 1 Jan 2010
Olivier Magali, Hollstein Monica, Hainaut Pierre
Abstract excerpt
Somatic mutations in the TP53 gene are one of the most frequent alterations in human cancers, and germline mutations are the underlying cause of Li-Fraumeni syndrome, which predisposes to a wide spectrum of early-onset cancers. Most mutations are single-base substitutions distributed throughout the coding sequence. Their diverse types and positions may inform on the nature of mutagenic mechanisms involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
